Liposomes as delivery systems for nasal vaccination: strategies and outcomes

B Heurtault, B Frisch, F Pons - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: Among the particulate systems that have been envisaged in vaccine
delivery, liposomes are very attractive. These phospholipid vesicles can indeed deliver a …

Recent advances in intranasal liposomes for drug, gene, and vaccine delivery

VA Duong, TTL Nguyen, HJ Maeng - Pharmaceutics, 2023 - mdpi.com
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

Mucosal vaccine development based on liposome technology

V Bernasconi, K Norling, M Bally… - Journal of …, 2016 - Wiley Online Library
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …

Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine

H Yusuf, AA Ali, N Orr, MM Tunney… - International journal of …, 2017 - Elsevier
There is a pressing need for effective needle-free vaccines that are stable enough for use in
the developing world and stockpiling. The inclusion of the cationic lipid DDA and the PEG …

Topical and mucosal liposomes for vaccine delivery

E Lilia Romero, MJ Morilla - Wiley Interdisciplinary Reviews …, 2011 - Wiley Online Library
Mucosal (and in minor extent transcutanous) stimulation can induce local or distant mucosa
secretory IgA. Liposomes and other vesicles as mucosal and transcutaneous adjuvants are …

Liposomal vaccine delivery systems

M Henriksen-Lacey, KS Korsholm… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Liposomes remain at the forefront of drug and vaccine design owing to their
well-documented abilities to act as delivery vehicles. Nevertheless, the concept of liposomes …

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

S Sharma, TKS Mukkur, HAE Benson… - Journal of pharmaceutical …, 2009 - Elsevier
The nasal route offers a promising opportunity for the delivery of vaccines. This review
analyses the opportunities and novel delivery strategies based on particulate systems for the …

Liposome-based vaccines for minimally or noninvasive administration: an update on current advancements

M Aroffu, ML Manca, JL Pedraz… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Vaccination requires innovation to provide effective protection. Traditional
vaccines have several drawbacks, which can be overcome with advanced technologies and …

Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits

M Amin, MR Jaafari, M Tafaghodi - Colloids and Surfaces B: Biointerfaces, 2009 - Elsevier
Liposomes have been identified as effective immunological adjuvants and have potential for
the intranasal and oral delivery of protein antigen. Anionic MLV liposomes were prepared by …

Liposomal constructs for antitumoral vaccination by the nasal route

Z Kakhi, B Frisch, B Heurtault, F Pons - Biochimie, 2016 - Elsevier
Mucosal surfaces are promising routes for vaccination. Among mucosa, airway mucosa
provides the opportunity to develop non-invasive approaches for vaccine delivery. In the …